Abbott’s medical device revenue reaches $5.5 billion
Abbott Laboratories operates across four major business segments, helping the company remain resilient through changing healthcare environments.
The company’s medical device business is its largest growth engine, with Q1 revenue reaching approximately $5.5 billion.
Within the medical device segment, diabetes care stands out, with the FreeStyle Libre platform generating roughly $2 billion in quarterly sales and over 7 million users worldwide.